🟢 Decoy Therapeutics is trading 5.7% up today as it rebounds from a recent pullback following its $21 million financing

Decoy Therapeutics is trading at $5.93 (+5.7%) in pre-market, staging a modest recovery after a 6.3% pullback on July 17.

• The stock's recent volatility follows a late-June surge driven by a $21 million private placement financing intended to fund clinical trials and the development of its Designable Multi-Antivirals platform.
• Trading volume remains relatively light with no fresh company-specific catalysts overnight as news-driven interest cools from the peak seen between June 26 and June 29.